Abstract | BACKGROUND: METHODS: A case-control study comparing 352 CHD patients and 395 controls was performed. Demographic, clinical, and laboratory characteristics were determined. RESULTS: The CHD patients had a higher mean concentration of Apo C(II) than controls (5.3 mg/dl compared with 4.2 mg/dl, P < 0.001). Elevated serum Apo C(II) concentration was associated with CHD presence after adjustment for cardiovascular risk factors. The risk factor-adjusted odds ratio (OR) for CHD was 1.60 (95% CI: 1.31-1.94) per 1 mg/dl increment in Apo C(II), compared with a risk factor-adjusted OR of 1.05 (95% CI: 0.85-1.32) per 40 mg/dl increment in triglyceride concentration. CONCLUSION: Increased serum concentration of Apo C(II) may represent a more sensitive marker of CHD than high serum concentration of triglycerides. Confirmation in cohort studies in required to establish or refute the role of elevated serum Apo C(II) as a risk factor for CHD.
|
Authors | Yariv Gerber, Uri Goldbourt, Hofit Cohen, Dror Harats |
Journal | Preventive medicine
(Prev Med)
Vol. 35
Issue 1
Pg. 42-7
(Jul 2002)
ISSN: 0091-7435 [Print] United States |
PMID | 12079439
(Publication Type: Evaluation Study, Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Apolipoprotein C-II
- Apolipoproteins C
- Triglycerides
|
Topics |
- Adult
- Aged
- Apolipoprotein C-II
- Apolipoproteins C
(blood)
- Case-Control Studies
- Coronary Disease
(blood, pathology)
- Demography
- Female
- Humans
- Male
- Middle Aged
- Risk Factors
- Triglycerides
(blood)
|